Press Releases MaaT Pharma Presents Promising Clinical Data from 76 Patients with Acute Graft-vs-Host-Disease Treated with MaaT013 at 63rd ASH Annual Meeting MaaT Pharma Presents Promising Clinical Data from 76 Patients with Acute Graft-vs-Host-Disease Treated with MaaT013…MaaT PharmaDecember 11, 2021
Press Releases Détails des opérations de stabilisation MaaT Pharma S.A. (« MaaT Pharma » ou la « Société »), société française de…MaaT PharmaDecember 6, 2021
Press Releases MaaT Pharma announces the partial exercise of the Over-Allotment Option and the total size of the Offering at approximately € 35.7m This announcement is not being made in and copies of it shall not be distributed…MaaT PharmaDecember 6, 2021
Press Releases MaaT Pharma Will Host Investor Information Meeting Following Presentation at ASH Conference of Additional Results on MaaT013 MaaT Pharma Will Host Investor Information Meeting Following Presentation at ASH Conference of Additional Results…MaaT PharmaDecember 1, 2021
Press Releases Details of all stabilization transactions Not for release, publication or distribution, in whole or in part, directly or indirectly in…MaaT PharmaNovember 16, 2021
Press Releases Opérations de stabilisation Ce communiqué ne peut être publié, distribué ou diffusé, directement ou indirectement, aux Etats-Unis d’Amérique,…MaaT PharmaNovember 16, 2021
Press Releases MaaT Pharma to Provide Additional Results from Phase II Trial and Expanded Access Program on MaaT013 in Oral Presentation at 63rd American Society of Hematology (ASH) Annual Meeting Results from HERACLES trial in 24 patients with GI-predominant, steroid-resistant grade III-IV aGvHD and from…MaaT PharmaNovember 9, 2021
Press Releases MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris MaaT PharmaNovember 3, 2021
Press Releases MaaT Pharma launches its initial public offering on the regulated market of Euronext in Paris Advertisement This announcement is not being made in and copies of it shall not be…MaaT PharmaOctober 15, 2021
Press Releases L’Alliance Promotion Microbiote présente les résultats de la première étude sur l’industrie du microbiote en France L’Alliance Promotion Microbiote présente les résultats de la première étude sur l’industrie du microbiote en…MaaT PharmaOctober 11, 2021